MetalloBio’s CEO is Awarded a Royal Academy of Engineering Enterprise Fellowship

MetalloBio’s CEO, Kirsty Smitten, has been awarded a competitive Enterprise Fellowship from The Royal Academy of Engineering.

The Fellowship will provide up to £60,000 equity free funding, tailored mentoring and training, a PR and marketing programme and access to the Enterprise Hub.

Based in Sheffield, South Yorkshire, MetalloBio is focussing on the development of novel antimicrobial compounds and antimicrobial materials to treat and prevent pathogenic, multi-drug resistant, Gram-negative bacterial infections. Antimicrobial resistance (AMR) is a global health threat. Currently AMR is responsible for 700,000 annual fatalities, it is predicted by 2050 this could rise to 10 million deaths per year costing a £66 trillion loss to the global economy.

This fellowship will focus on the development of antimicrobial materials for medical and non-medical applications. Antimicrobial materials are required to prevent biofilm formation on surfaces and medical devices such as catheters, stents, endotracheal tubes and prosthetic limbs. This will include applications such as medical device coatings and antimicrobial paints. MetalloBio’s pipeline compounds will be incorporated into the antimicrobial materials.

Kirsty Smitten, CEO of MetalloBio, said: “I’m incredibly proud to have been awarded the Fellowship, the training and support it will provide will help MetalloBio to develop prototypes and accelerate the technology’s development for antimicrobial material applications. We hope to leverage the research completed in the Fellowship to secure further funding or facilitate future partnerships.

For further information contact:

MetalloBio Limited

Kirsty Smitten

email: metallobio@gmail.com